From Dreams to Psychedelics: Tommaso’s Academic Odyssey
Tommaso Barba, a visionary in psychedelic research, advances knowledge and accessibility, bridging diverse fields for a brighter future.
Tommaso Barba, a visionary in psychedelic research, advances knowledge and accessibility, bridging diverse fields for a brighter future.
PsychedelicsEUROPE is shaping the European psychedelic landscape, influencing policies, and addressing mental health crises. Their MEP action group aims to accelerate EU regulatory changes.
This is all the other psychedelic research that came out in October 2023. These papers don’t (yet) have their own page in our database.
It’s been quite a few months since the last update (May). In that time, Blossom has continued to expand, with us now having full summaries of nearly 2000 research articles. When we hit this milestone (probably mid November), I will make a bit of a splash around it.
The psychedelic research that was published in September 2023. From new trials to guidelines. Psychedelic studies that were impactful this month.
Even as many of us took time off for summer vacations, researchers in the field of psychedelics persisted in their efforts. They delved deeper into understanding the healing properties of these substances. The big psilocybin for depression (MDD) by the non-profit Usona was published, we got new insights into candy flipping (MDMA + psychedelic) from two groups, and the risks of prolonged microdosing.
This is all the other psychedelic research that came out in September 2023. These papers don’t (yet) have their own page in our database.
This is all the other psychedelic research that came out in August 2023. These papers don’t (yet) have their own page in our database.
The top psychedelic research papers by citations with explanation of what each research article contributes to the literature.
This is all the other psychedelic research that came out in July 2023. These papers don’t (yet) have their own page in our database.